Sichuan Hebang Financials
| 603077 Stock | 2.04 0.01 0.49% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 1.1 B | 1.5 B |
|
|
Sichuan | Select Account or Indicator |
Understanding current and past Sichuan Hebang Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Sichuan Hebang's financial statements are interrelated, with each one affecting the others. For example, an increase in Sichuan Hebang's assets may result in an increase in income on the income statement.
Please note, the presentation of Sichuan Hebang's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sichuan Hebang's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sichuan Hebang's management manipulating its earnings.
Sichuan Hebang Stock Summary
Sichuan Hebang competes with Zijin Mining, Wanhua Chemical, Baoshan Iron, Shandong Gold, and Inner Mongolia. Sichuan Hebang is entity of China. It is traded as Stock on SHG exchange.Specialization | Basic Materials, Materials |
| Instrument | China Stock View All |
| Exchange | Shanghai Stock Exchange |
| ISIN | CNE100001JM9 |
| Business Address | Mianba Village, Leshan, |
| Sector | Chemicals |
| Industry | Materials |
| Benchmark | Dow Jones Industrial |
| Website | www.hebang.cn |
| Phone | 86 28 6205 0230 |
You should never invest in Sichuan Hebang without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Sichuan Stock, because this is throwing your money away. Analyzing the key information contained in Sichuan Hebang's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Sichuan Hebang Key Financial Ratios
Sichuan Hebang's financial ratios allow both analysts and investors to convert raw data from Sichuan Hebang's financial statements into concise, actionable information that can be used to evaluate the performance of Sichuan Hebang over time and compare it to other companies across industries.| Revenue | 8.82 B | ||||
| Gross Profit | 5.55 B | ||||
| EBITDA | 1.61 B | ||||
| Net Income | 1.28 B | ||||
| Total Asset | 24.54 B |
Sichuan Hebang Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 14.5B | 14.7B | 17.9B | 24.1B | 24.5B | 12.9B | |
| Other Current Liab | 108.7M | 149.4M | 574.4M | 377.3M | 9.7M | 9.2M | |
| Other Liab | 20.1M | 18.2M | 56.8M | 175.1M | 201.3M | 211.4M | |
| Retained Earnings | 2.6B | 2.6B | 5.6B | 9.3B | 9.6B | 10.1B | |
| Accounts Payable | 971.1M | 1.0B | 1.2B | 1.9B | 1.9B | 2.0B | |
| Cash | 590.5M | 845.9M | 1.7B | 4.6B | 3.1B | 3.2B | |
| Other Assets | 466.0M | 341.1M | 450.3M | 242.1M | 278.5M | 396.5M | |
| Long Term Debt | 226M | 262.4M | 68.1M | 408.5M | 431.2M | 520.4M | |
| Net Receivables | 1.1B | 518.9M | 497.6M | 778.0M | 977.6M | 753.3M | |
| Inventory | 1.3B | 633.3M | 912.2M | 2.1B | 4.4B | 4.6B | |
| Other Current Assets | 228.8M | 142.0M | 287.8M | 460.2M | 112.9M | 107.3M | |
| Total Liab | 3.0B | 3.4B | 3.3B | 4.3B | 4.3B | 3.3B | |
| Intangible Assets | 1.1B | 1.0B | 2.0B | 2.2B | 824.9M | 1.1B | |
| Net Tangible Assets | 8.2B | 8.2B | 10.4B | 15.1B | 17.4B | 9.7B | |
| Short Long Term Debt | 1.6B | 1.6B | 1.2B | 1.2B | 1.2B | 1.1B | |
| Total Current Assets | 3.5B | 3.3B | 4.6B | 9.7B | 9.9B | 5.4B | |
| Net Invested Capital | 13.1B | 13.0B | 15.5B | 20.7B | 21.2B | 16.9B | |
| Net Working Capital | 706.8M | 165.6M | 1.5B | 6.0B | 6.2B | 6.5B |
Sichuan Hebang Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 57.0M | 82.2M | 77.8M | 51.4M | 24.4M | 25.8M | |
| Total Revenue | 6.0B | 5.3B | 9.9B | 13.0B | 8.8B | 5.1B | |
| Operating Income | 671.2M | 530.9M | 3.7B | 4.5B | 1.5B | 1.1B | |
| Cost Of Revenue | 4.6B | 4.3B | 5.7B | 7.5B | 6.8B | 3.5B | |
| Income Before Tax | 583.8M | 15.8M | 3.6B | 4.5B | 1.5B | 1.0B | |
| Net Income | 516.9M | 40.9M | 3.0B | 3.8B | 1.3B | 862.7M | |
| Income Tax Expense | 77.1M | 12.9M | 551.9M | 668.3M | 768.6M | 807.0M | |
| Gross Profit | 1.4B | 988.8M | 4.1B | 5.6B | 2.1B | 2.2B | |
| Ebit | 643.2M | 522.5M | 3.7B | 4.5B | 5.2B | 5.4B | |
| Research Development | 38.3M | 39.7M | 33.3M | 67.9M | 47.3M | 43.1M | |
| Minority Interest | 219.5M | 165.7M | (8.0M) | (3.4M) | 4.5M | 4.3M | |
| Tax Provision | 77.1M | 12.9M | 551.9M | 668.3M | 257.3M | 250.8M | |
| Net Interest Income | (56.7M) | (88.0M) | (69.7M) | (29.3M) | 34.4M | 36.1M | |
| Interest Income | 6.9M | 3.7M | 9.4M | 22.7M | 60.4M | 63.4M | |
| Ebitda | 1.3B | 740.9M | 4.3B | 5.5B | 6.3B | 6.6B |
Sichuan Hebang Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Sichuan Hebang Biote. It measures of how well Sichuan is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Sichuan Hebang brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Sichuan had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Sichuan Hebang has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Dividends Paid | 71.1M | 92.7M | 78.0M | 197.8M | 463.6M | 486.8M | |
| Capital Expenditures | 662.5M | 197.1M | 1.8B | 936.2M | 828.7M | 767.6M | |
| Net Income | 516.9M | 40.9M | 3.0B | 3.8B | 1.3B | 862.7M | |
| Change To Inventory | (269.2M) | 678.3M | (278.9M) | (1.2B) | (2.3B) | (2.2B) | |
| Investments | (55.3M) | (56.0M) | (15.8M) | 57.8M | (782.2M) | (743.1M) | |
| Change In Cash | (737.1M) | 263.1M | 844.3M | 2.9B | (1.6B) | (1.6B) | |
| Net Borrowings | 677.8M | 285.2M | (819.5M) | 442.3M | 508.6M | 534.1M | |
| Depreciation | 635.6M | 643.0M | 643.9M | 929.5M | 1.0B | 696.1M | |
| Change To Netincome | 73.7M | 46.8M | 71.8M | 84.4M | 97.1M | 81.7M | |
| End Period Cash Flow | 573.5M | 836.7M | 1.7B | 4.5B | 2.9B | 1.8B | |
| Free Cash Flow | (499.6M) | 171.8M | 1.5B | 1.7B | (748.4M) | (711.0M) | |
| Other Non Cash Items | 60.8M | 117.5M | 93.7M | 47.4M | 27.5M | 26.1M |
Sichuan Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sichuan Hebang's current stock value. Our valuation model uses many indicators to compare Sichuan Hebang value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sichuan Hebang competition to find correlations between indicators driving Sichuan Hebang's intrinsic value. More Info.Sichuan Hebang Biotechnology is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.60 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Sichuan Hebang Biotechnology is roughly 1.66 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sichuan Hebang by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sichuan Hebang's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Sichuan Hebang Biote Systematic Risk
Sichuan Hebang's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Sichuan Hebang volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Sichuan Hebang Biote correlated with the market. If Beta is less than 0 Sichuan Hebang generally moves in the opposite direction as compared to the market. If Sichuan Hebang Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Sichuan Hebang Biote is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Sichuan Hebang is generally in the same direction as the market. If Beta > 1 Sichuan Hebang moves generally in the same direction as, but more than the movement of the benchmark.
Sichuan Hebang Biotechnology Total Assets Over Time
Sichuan Hebang Thematic Clasifications
Sichuan Hebang Biotechnology is part of Biotech investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services
This theme covers Biotechnology and pharmaceuticals production and services. Companies specialized in biotechnology production and delivery of pharmaceuticals services. Get More Thematic Ideas
| Biotech | View |
Sichuan Hebang December 1, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Sichuan Hebang help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Sichuan Hebang Biotechnology. We use our internally-developed statistical techniques to arrive at the intrinsic value of Sichuan Hebang Biotechnology based on widely used predictive technical indicators. In general, we focus on analyzing Sichuan Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Sichuan Hebang's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.42 | |||
| Information Ratio | 0.0816 | |||
| Maximum Drawdown | 18.14 | |||
| Value At Risk | (3.03) | |||
| Potential Upside | 3.93 |
Complementary Tools for Sichuan Stock analysis
When running Sichuan Hebang's price analysis, check to measure Sichuan Hebang's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sichuan Hebang is operating at the current time. Most of Sichuan Hebang's value examination focuses on studying past and present price action to predict the probability of Sichuan Hebang's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sichuan Hebang's price. Additionally, you may evaluate how the addition of Sichuan Hebang to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |